OHSU in the news

Serendipity And Science: Forging Billion-Dollar Oncology Breakthroughs

Forbes January 31, 2024
A Forbes article details the background of how the drug nirogacestat received FDA approval for the treatment of desmoid tumors. Shivaani Kummar, M.D., who conducted the Phase 2 clinical trial study while at the National Cancer Institute, says: “Desmoid tumors can result in significant impact on functioning and quality of life of patients. Seeing the responses and clinical benefit reported by the investigators in the Phase I trial, I felt strongly that we should further evaluate this new drug for its likelihood to benefit patients with this rare tumor.”

Using neuroimaging, researchers confirm cumulative, brain-wide effects of ADHD

Medical Xpress January 31, 2024
OHSU researcheres leveraged a large national dataset and neuroimaging to confirm the brain-wide effects of ADHD. Michael Mooney, Ph.D., says, “By evaluating the cumulative effects of regions across the entire brain, we are now looking at ADHD as a whole-brain issue, which could make it easier to predict which kids have ADHD and how severe it may be. Down the road, we hope this will help with early identification of kids at most risk, so they can get the help they need as soon as possible.”

Switching Twice With Infliximab Biosimilars Not Linked With IBD Flare Risk

MedPage Today January 28, 2024
Elisa Boden, M.D., provides outside expert commentary on a study that found switching to medications that are biosimilar to the inflammatory bowel disease drug infliximab does not cause flare-ups. She says, “This study gives me data to be able to tell patients that they don’t need to worry if their insurance is requiring them to switch.”

What parrots can teach us about human intelligence

Science News January 26, 2024
Claudio Mello M.D., Ph.D., shares insight on how parrots can give clues to the evolution of human intelligence: “Parrots have acquired duplicate copies of various genes, some of which are known to be important for brain development and speech in people.”

Congress must pass the child tax credit deal to support kids’ health

STAT January 26, 2024
In a column for Stat News, Ben Hoffman, M.D., calls on Congress to approve a bipartisan tax package that would help the child tax credit reach more families: “We need our lawmakers to act without delay if we are to reverse the alarming trends in child poverty we’ve witnessed. When we support children with evidence-based programs and services to address their basic needs, we support their lifelong health and development, improving their well-being and decreasing risk for adverse outcomes. Simply put, this can set up future generations for success.”

Precision Medicine: An Innovative Approach to Treating Cancer

National Academies Sciences Engineering Medicine January 25, 2024
Gordon Mills, M.D., Ph.D., will give a webinar presentation to the National Academies of Science, Engineering and Medicine on the impact of personalized medicine on the FDA approval process and the results of the SMMART Clinical Trial, which tracks a patient’s cancer over time through biopsies and tests, and uses that information to adjust drug combinations to stay ahead of the cancer.
See more stories